Covid-19 research
COVID-19 has complex clinical presentation with severe respiratory effects and
multi-organ failure in some
A rapidly evolving clinical picture pinpoints abnormal clotting and platelet dysfunction when analyzing Cov-19.
Our initial research has shown thrombolytic and anti-platelet therapy may offer greatest impact on severe covid-19 disease.
COVID-19 pathophysiology suggests the possibility that GSTP elevations would precede clinical decline in many cases.
An ongoing topic of concern
As the global pandemic shook the foundation of society, its relevance remains key in our work.
Want to know more?
Much of our research in this sector is confidential. If you are interested in investing in this research, or are a medical sciences company, please contact us below.